Adapting behavioural interventions to compensate for cognitive dysfunction in persons with opioid use disorder.

addictive behavior behavior research cognitive dysfunction

Journal

General psychiatry
ISSN: 2517-729X
Titre abrégé: Gen Psychiatr
Pays: England
ID NLM: 101735271

Informations de publication

Date de publication:
2021
Historique:
received: 23 09 2020
accepted: 21 07 2021
entrez: 10 9 2021
pubmed: 11 9 2021
medline: 11 9 2021
Statut: epublish

Résumé

Treatment for opioid use disorder (OUD) is often in the context of biobehavioural interventions, consisting of medication for OUD (for example, methadone and buprenorphine), which is accompanied by psychoeducation and/or behavioural therapies. Patients with OUD often display weaknesses in cognitive function that may impact the efficacy of such behavioural interventions. A review of the literature was conducted to: (1) describe common cognitive dysfunction profiles among patients with OUD, (2) outline intervention approaches for patients with OUD, (3) consider the cognitive demands that interventions place on patients with OUD and (4) identify potential accommodation strategies that may be used to optimise treatment outcomes. Cognitive profiles of patients with OUD often include weaknesses in executive function, attention, memory and information processing. Behavioural interventions require the patients' ability to learn, understand and remember information (placing specific cognitive demands on patients). Accommodation strategies are, therefore, needed for patients with challenges in one or more of these areas. Research on accommodation strategies for patients with OUD is very limited. We applied research from populations with similar cognitive profiles to form a comprehensive collection of potential strategies to compensate for cognitive dysfunction among patients with OUD. The cognitive profiles and accommodation strategies included in this review are intended to inform future intervention research aimed at improving outcomes among patients with OUD.

Identifiants

pubmed: 34504995
doi: 10.1136/gpsych-2020-100412
pii: gpsych-2020-100412
pmc: PMC8370499
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e100412

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Clin Child Adolesc Psychol. 2012;41(5):654-65
pubmed: 22867130
BMC Psychiatry. 2019 Jul 24;19(1):228
pubmed: 31340791
Addiction. 2013 Mar;108(3):566-74
pubmed: 23164063
Drug Alcohol Depend. 2007 May;88 Suppl 2:S24-30
pubmed: 17056207
J Atten Disord. 2008 Nov;12(3):218-26
pubmed: 18192618
Drug Alcohol Depend. 2007 Sep;90 Suppl 1:S85-91
pubmed: 17101239
Drug Alcohol Depend. 2016 Apr 1;161:247-57
pubmed: 26905209
Drug Alcohol Depend. 2007 Sep 6;90(1):25-38
pubmed: 17382488
Gen Psychiatr. 2019 Feb 23;32(1):e100054
pubmed: 31179427
Psychopharmacology (Berl). 2012 Jun;221(3):361-87
pubmed: 22441659
Brain Inj. 2004 May;18(5):461-70
pubmed: 15195794
Drug Alcohol Rev. 2019 May;38(4):435-442
pubmed: 30916448
AIDS Behav. 2016 Aug;20(8):1646-57
pubmed: 27052845
Behav Res Ther. 2005 Jul;43(7):831-42
pubmed: 15896281
AIDS Care. 2012;24(3):386-93
pubmed: 22250847
Neurosci Biobehav Rev. 2012 Oct;36(9):2056-68
pubmed: 22771335
J Consult Clin Psychol. 2012 Aug;80(4):700-6
pubmed: 22545736
Atten Defic Hyperact Disord. 2017 Jun;9(2):73-88
pubmed: 27614892
AIDS Behav. 2010 Dec;14(6):1213-26
pubmed: 20232242
NeuroRehabilitation. 2002;17(4):333-44
pubmed: 12547981
Perspect Psychol Sci. 2014 Mar;9(2):161-79
pubmed: 25544856
Brain. 2010 Jul;133(Pt 7):2098-114
pubmed: 20558415
AIDS Care. 2017 Jan;29(1):73-78
pubmed: 27338092
Psychiatr Clin North Am. 2010 Sep;33(3):497-509
pubmed: 20599129
Curr Psychiatry Rep. 2010 Feb;12(1):20-7
pubmed: 20425306
Psychiatr Clin North Am. 2010 Sep;33(3):511-25
pubmed: 20599130
J Atten Disord. 2006 Nov;10(2):150-9
pubmed: 17085625
Neurosci Biobehav Rev. 2012 Apr;36(4):1163-78
pubmed: 22322184
Health Psychol. 2003 Mar;22(2):223-8
pubmed: 12683743
Lancet. 2010 Jul 31;376(9738):367-87
pubmed: 20650518
J Subst Abuse Treat. 2017 Jan;72:80-88
pubmed: 27590364
Am J Geriatr Psychiatry. 2013 Mar;21(3):242-50
pubmed: 23395191
Pain Physician. 2014 Jan-Feb;17(1):9-20
pubmed: 24452649
Drug Alcohol Depend. 2020 Apr 1;209:107884
pubmed: 32078973
Annu Rev Public Health. 2018 Apr 1;39:525-541
pubmed: 29272165
Psychol Bull. 2006 May;132(3):354-80
pubmed: 16719566
J Psychoactive Drugs. 2003 Apr-Jun;35(2):209-18
pubmed: 12924743
Neuropharmacology. 2013 Jan;64:452-63
pubmed: 22735770
J Med Internet Res. 2017 Aug 30;19(8):e301
pubmed: 28855146
Indian J Psychol Med. 2016 May-Jun;38(3):172-81
pubmed: 27335510
Aging Ment Health. 2003 Jan;7(1):22-7
pubmed: 12554311
Neuropsychol Rehabil. 2019 Jan;29(1):1-21
pubmed: 27873549
Behav Cogn Psychother. 2009 Mar;37(2):141-50
pubmed: 19364415
J Affect Disord. 2013 Jul;149(1-3):1-13
pubmed: 23528438
Drug Alcohol Depend. 2015 Nov 1;156:38-46
pubmed: 26404954
Hum Psychopharmacol. 2012 Sep;27(5):499-506
pubmed: 22996617
J Subst Abuse Treat. 2016 Jun;65:1-5
pubmed: 26971078
Neuropsychol Rehabil. 2019 Sep;29(8):1273-1289
pubmed: 29161998
Patient Prefer Adherence. 2020 Jan 16;14:107-118
pubmed: 32021122
Drug Alcohol Depend. 2021 Jul 1;224:108726
pubmed: 33930640
Neuropsychol Rev. 2007 Sep;17(3):317-36
pubmed: 17690986
PLoS One. 2017 Sep 27;12(9):e0184964
pubmed: 28953946
Addiction. 2004 Apr;99(4):461-71
pubmed: 15049746
Indian J Psychol Med. 2014 Apr;36(2):112-8
pubmed: 24860208
J Atten Disord. 2008 May;11(6):728-36
pubmed: 17712167
Neuropsychol Rev. 2004 Mar;14(1):1-41
pubmed: 15260137
J Int Neuropsychol Soc. 2012 Jan;18(1):1-19
pubmed: 22152338
AIDS Care. 2017 Sep;29(9):1144-1148
pubmed: 28478706
Appl Neuropsychol Adult. 2020 May 28;:1-7
pubmed: 32463730
Ann N Y Acad Sci. 2014 Oct;1327:62-78
pubmed: 25336389
Gen Psychiatr. 2021 Feb 18;34(1):e100338
pubmed: 33728399
Gen Psychiatr. 2019 Oct 9;32(5):e100087
pubmed: 31673676
Gen Psychiatr. 2020 Jun 4;33(3):e100220
pubmed: 32548569
Genes Brain Behav. 2017 Jan;16(1):205-218
pubmed: 27573875
J Exp Anal Behav. 2011 Nov;96(3):363-85
pubmed: 22084496
Schizophr Bull. 2005 Oct;31(4):922-30
pubmed: 16037481
J Head Trauma Rehabil. 2007 Sep-Oct;22(5):303-13
pubmed: 17878772
Curr Opin Infect Dis. 2015 Feb;28(1):10-6
pubmed: 25490106
Ann Behav Med. 2005 Aug;30(1):65-73
pubmed: 16097907
Psychiatry Res Neuroimaging. 2016 Apr 30;250:12-4
pubmed: 27107155
J Consult Clin Psychol. 2016 Oct;84(10):861-73
pubmed: 27281374
BMJ. 2006 Feb 25;332(7539):455-9
pubmed: 16452102
Am J Alzheimers Dis Other Demen. 2018 May;33(3):184-191
pubmed: 29357670
BMC Psychiatry. 2006 Feb 24;6:9
pubmed: 16504127
Contemp Clin Trials. 2013 Jan;34(1):45-52
pubmed: 23010608
Ann N Y Acad Sci. 2014 Oct;1327:94-111
pubmed: 25204847
Psychopharmacology (Berl). 2007 Mar;190(4):517-30
pubmed: 17136401

Auteurs

Colleen B Mistler (CB)

Allied Health Sciences, University of Connecticut, Storrs, Connecticut, USA.

Roman Shrestha (R)

Allied Health Sciences, University of Connecticut, Storrs, Connecticut, USA.

John Gunstad (J)

Department of Psychology, Kent State University, Kent, Ohio, USA.

Victoria Sanborn (V)

Department of Psychology, Kent State University, Kent, Ohio, USA.

Michael M Copenhaver (MM)

Allied Health Sciences, University of Connecticut, Storrs, Connecticut, USA.

Classifications MeSH